« Return to News | R&D Trends | CROs/Service Providers

GVK partners with Gates Foundation

Monday, May 16, 2011 12:44 PM

India-based CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.

Under the terms of the agreement, GVK will provide clinical support, logistics, monitoring and project management for trials PDP is conducting in India and Bangladesh.  PDP is a group of non-profit entities partially funded by the Bill and Melinda Gates Foundation.

PDP’s target illnesses include tuberculosis, malaria, HIV, pneumonia and diarrhea which, despite affecting millions of people, are often overlooked by drug companies in favor of conditions that can generate more income. 

Shoibal Mukherjee, senior vice president of clinical development at GVK, said, “GVK Biosciences has been working in the area of neglected diseases for several years, and it is this experience that puts the company in a position to participate in the Global Health Product Development Partners Consortium.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013
Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings
Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving
Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.